Balyasny Asset Management
PAHC icon

Balyasny Asset Management’s Phibro Animal Health PAHC Stock Holding History

Balyasny Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,669
Closed -$426K – 3331
2025
Q2 		$426K Buy
+16,669
New +$363K ﹤0.01% 2353
2023
Q1 		– Sell
-13,318
Closed -$179K – 3019
2022
Q4 		$179K Buy
+13,318
New +$179K ﹤0.01% 2157
2017
Q2 		– Sell
-10,200
Closed -$287K – 1664
2017
Q1 		$287K Buy
+10,200
New +$288K ﹤0.01% 1412
2016
Q2 		– Sell
-7,770
Closed -$210K – 1373
2016
Q1 		$210K Buy
+7,770
New +$223K ﹤0.01% 1113
2015
Q4 		– Sell
-7,900
Closed -$250K – 1392
2015
Q3 		$250K Sell
7,900
-1,685
-18% -$61.5K ﹤0.01% 961
2015
Q2 		$373K Buy
+9,585
New +$331K ﹤0.01% 917

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management's PAHC Position: Q3 2025 in Review

Balyasny Asset Management sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 16,669 shares — an estimated $426K sold.

Balyasny Asset Management first reported a position in PAHC in Q2 2015 and held it in 6 quarters. The position peaked at $426K in Q2 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Balyasny Asset Management reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 16,669 Phibro Animal Health shares in Q3 2025, an estimated $426K.
  • Balyasny Asset Management first reported a position in Phibro Animal Health in Q2 2015 and held it in 6 quarters.
  • Balyasny Asset Management's Phibro Animal Health position peaked at $426K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.